Bristol-Myers Squibb Company Revenue 2007–2025
Bristol-Myers Squibb Company reported $48.19B of revenue for fiscal 2025. That was 0.2% lower than fiscal 2024. Compared with fiscal 2020, the change was +13.3%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $48.19B | -0.2% |
| FY 2024 | $48.30B | +7.3% |
| FY 2023 | $45.01B | -2.5% |
| FY 2022 | $46.16B | -0.5% |
| FY 2021 | $46.38B | +9.1% |
| FY 2020 | $42.52B | +62.6% |
| FY 2019 | $26.14B | +15.9% |
| FY 2018 | $22.56B | +8.6% |
| FY 2017 | $20.78B | +6.9% |
| FY 2016 | $19.43B | +17.3% |
| FY 2015 | $16.56B | +4.3% |
| FY 2014 | $15.88B | -3.1% |
| FY 2013 | $16.39B | -7.0% |
| FY 2012 | $17.62B | -17.1% |
| FY 2011 | $21.24B | +9.0% |
| FY 2010 | $19.48B | +3.6% |
| FY 2009 | $18.81B | +6.2% |
| FY 2008 | $17.71B | +13.4% |
| FY 2007 | $15.62B | — |
Source: Bristol-Myers Squibb Company SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open BMY 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Bristol-Myers Squibb Company reported $48.19B of revenue for fiscal 2025. That was 0.2% lower than fiscal 2024. Compared with fiscal 2020, the change was +13.3%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Bristol-Myers Squibb Company
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBristol-Myers Squibb Company — frequently asked questions
What is Bristol-Myers Squibb Company's revenue?
Bristol-Myers Squibb Company (BMY) reported revenue of $48.19B for fiscal year 2025, per its SEC filings.
How has Bristol-Myers Squibb Company's revenue changed over time?
Between fiscal 2007 and 2025, BMY's revenue grew at roughly 6.5% per year (compound annual rate), from $15.62B to $48.19B.
Where does this data come from?
Figures are computed from Bristol-Myers Squibb Company's official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.